TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive UT Health System’s Probe Finds Lapses at MD Anderson, CPRIT—But No Nepotism June 15, 2012
TCL Archive Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent June 21, 2013
TCL Archive Bill to Rebalance Chemotherapy Drug Payments, Physician Services, Introduced in House April 11, 2003
TCL Archive Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial July 25, 2014
